2026 NPPES data Pharmacist NPI 1033716048
Verify on CMS →

ARDALAN DOROST

Pharmacist in YORK, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
85
Medicare Part D claims · 80 beneficiaries · Pharmacist avg: 135
Generic prescribing
0%
generic claims · 100% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

ARDALAN DOROST filed 85 Medicare Part D claims in 2023 as a Pharmacist in YORK, Pennsylvania, prescribing 0% generic.

85
Part D claims, 2023
0%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ARDALAN DOROST's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

85 0th percentile higher than 0% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about ARDALAN DOROST?

Quality data not reported

NPI registry status

Active

Issued 10/02/2020

NPI 1033716048

Primary specialty

Pharmacist

High-volume

290,447 US NPIs in this specialty

Medicare Part D claims

85 37% vs specialty avg

2023 prescription claims

Specialty avg: 135

Specialty distribution in Pennsylvania

How Pharmacist compares to other specialties among Pennsylvania providers

Pennsylvania providers

Pharmacist share within Pennsylvania

1. Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacist share within Pennsylvania

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ARDALAN DOROST appears in the CMS NPPES registry as a Pharmacist provider at 115 LEADERS HEIGHTS RD, YORK, PA, 17403, with a listed phone of (717) 741-0823. NPI 1033716048 was issued on 10/02/2020. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DOROST most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 85 prescription claims written by this provider, covering 80 Medicare beneficiaries and totaling roughly $24K in drug spend, split 100% brand-name and 0% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacist is a high-volume specialty nationwide, with 290,447 enrolled providers across 56 states and an average of 135 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

115 LEADERS HEIGHTS RD
YORK, PA 17403

Provider Details

NPI 1033716048
Specialty Pharmacist
Gender Male
NPI Issued 10/02/2020

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to ARDALAN DOROST. To verify ARDALAN DOROST's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

ARDALAN DOROST — brand share 100.0%
Specialty average (est.)

100% brand-name claims vs 0% generic, on 85 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

85
Total Claims
$24K
Total Drug Cost
80
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
85
Total Day Supply
85
Brand vs Generic
100% brand / 0% generic
Brand Drug Cost
$24K
Generic Drug Cost
$0

Patient Demographics

Average Patient Age
76.4 years
Avg HCC Risk Score
0.96
Gender Split
55% female / 45% male
Age Distribution
<65: 0, 65-74: 29, 75-84: 39, 85+: 12

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Shingrix
Varicella-Zoster Ge/As01b/Pf
18
Abrysvo
"Rsv Vacc
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacist Overview

How ARDALAN DOROST fits within the Pharmacist landscape nationally.

290,447
Pharmacist Providers in US
56
States with Pharmacist
135
Avg Claims per Provider

ARDALAN DOROST's 85 claims are below the specialty average of 135.

Nearby Pharmacist Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as DOROST.

Compare Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is ARDALAN DOROST's specialty?
ARDALAN DOROST specializes in Pharmacist and practices in YORK, Pennsylvania.
How much does ARDALAN DOROST prescribe under Medicare Part D?
In 2023, ARDALAN DOROST wrote 85 Medicare Part D claims totaling $24K in drug costs for 80 beneficiaries.
Where is ARDALAN DOROST located?
ARDALAN DOROST is located at 115 LEADERS HEIGHTS RD, YORK, PA, 17403. Phone: (717) 741-0823.
What is ARDALAN DOROST's NPI number?
ARDALAN DOROST's National Provider Identifier (NPI) is 1033716048, issued on 10/02/2020.
Does ARDALAN DOROST prescribe more brand-name or generic drugs?
ARDALAN DOROST's prescribing is 100% brand-name and 0% generic drugs by claim count, with $24K in brand drug costs.
How many Pharmacist providers are there in the US?
There are 290,447 Pharmacist providers across 56 states in the US. The average Pharmacist provider writes 135 Medicare Part D claims per year.
What drugs does ARDALAN DOROST prescribe most often?
Based on 2023 Medicare Part D data, ARDALAN DOROST's most frequently prescribed drugs include Shingrix, Abrysvo. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ARDALAN DOROST accept Medicare?
ARDALAN DOROST appears in CMS Medicare data with 85 Part D claims and 80 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ARDALAN DOROST's credentials?
ARDALAN DOROST's NPI is 1033716048. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology